Orchid Ventures Enters into One of the Largest Acquisitions Made by a US Cannabis Brand
IRVINE, CA and VANCOUVER, BC / ACCESSWIRE / July 3, 2019 / Premium cannabis brand Orchid Ventures, Inc. (CSE: ORCD) (OTC PINK: ORVRF) (“Orchid Ventures” or the “Company“) announces that the Company has entered into an asset purchase agreement (the “Definitive Agreement“) on July 2, 2019, for the acquisition of certain assets of GreenBloom Cannabis Co. (“GreenBloom“), a vertically-integrated cannabis operator with five retail stores , two cultivation facilities, one distribution entity, and six brands in Oregon and California (the “Acquisition“).
Also part of the Acquisition is a development in California of cultivation, processing, and retail facility with 300,000 square feet of canopy, and a 25,000 square foot extraction facility, which would make it one of the largest facilities in the State of California once developed. The Acquisition will provide Orchid Ventures with a vertically integrated operator, with current projected revenue of up to CA$163.7MM for the next twelve months with an estimated EBITDA of 13.6% (actual EBITDA of 2018 was 13.6%), and would establish one of the largest West Coast-centric cannabis conglomerates in the industry.
Orchid Ventures currently sells a premium line of vaporized products, plus an expanding line of new CBD and THC products across several categories in California and Oregon. With this acquisition, Orchid will also add to their portfolio of brands and significantly increase cash flow in order to accelerate development and expansion into existing and new markets. Importantly, Orchid will control a sophisticated and quality supply-chain from seed to sale, cementing itself as one of the most diverse and robust cannabis portfolios in the industry.
“This is a tremendous alignment of interests between not just two companies but in a sector in need of innovation, expansion and growth that has been proven by GreenBloom Cannabis and their leadership”, said Tom Soto, Board Chairman of Orchid Ventures, Inc, “the strength in the markets that GreenBloom has demonstrated, partnering with the premier consumer brand in Orchid Essentials makes for a highly valued, consumer-driven acquisition that will further define where the cannabis sector could scale.”
“For the last year, I have worked closely with GreenBloom Cannabis, visiting all their facilities, meeting with their teams, and developing a great relationship with management. The alignment of our two organizations will greatly increase margins and solidify the supply chain in both California and Oregon,” said Corey Mangold, Founder & CEO of Orchid Ventures, Inc. “Along with adding a large amount of revenue and EBITDA, we are greatly furthering our capabilities to expand Orchid Essentials into multiple new states and countries in the coming year. Having George Mattia join the executive leadership team along with joining the Board of Directors, will add tremendous value and operational skills to the organization.”
“My initial vision in establishing GreenBloom Cannabis was to create a profitable health and well-being based cannabis company that takes consumers, the community, and the future of this sector in mind,” said George Mattia, Founder, and CEO of GreenBloom. “In joining forces with the Orchid family we will be in a stronger position to leverage our cultivation, processing and retail assets and expertise with Orchid’s product innovation capability, and their proven success in building great brands through disruptive marketing and sales excellence. Choosing Orchid Ventures also allows us to scale our combined businesses to serve even more consumers and provide the highest quality cannabis products at affordable prices.”
Pursuant to the terms of the Definitive Agreement, in consideration for the Acquisition and upon closing thereof, the Company will pay an aggregate purchase price of US$10,000,000 to be paid out over the next 12 months, and issue 50,000,000 common shares at a deemed price of CA$0.50 per share (the “Payment Shares“). The Payment Shares will be subject to escrow conditions and/or resale restrictions as required by applicable securities laws and the policies of the CSE as well as additional voluntary hold periods agreed to by GreenBloom. There are no finders fees, nor change of control.
The Acquisition is subject to certain closing conditions, including, without limitation, completion of due diligence by each party. There can be no assurance that the Acquisition will be completed as proposed or at all. The Acquisition is currently expected to close in August 2019.
In addition, the Company also announces that it has entered into a Memorandum of Understanding (“MOU“) with Infusion Factory, LLC (“Infusion“) and its parent company ICON Holdings, Inc. pursuant to which Infusion will provide vendor services in exchange for, among other things, the issuance of a warrant (“Warrant“) to purchase of up to 200,000 Shares at the price of CAD$0.33 per share with a term of 36 months. The issuance of the Warrant is subject to the approval of the Exchange. In addition, the Company issued 2,000,000 stock options, which vested immediately, at the exercise price of CAD$0.33 to its independent directors.
None of the securities to be issued pursuant to the Acquisition or the Warrant have been or will be registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act“), or any state securities laws and any securities issued pursuant to the Acquisition and Warrant are anticipated to be issued in reliance upon available exemptions from such registration requirements pursuant to Rule 506(b) of Regulation D and/or Section 4(a)(2) of the U.S. Securities Act and applicable exemptions under state securities laws. In addition, the securities issued under an exemption from the registration requirements of the U.S. Securities Act will be “restricted securities” as defined under Rule 144(a)(3) of the U.S. Securities Act and will contain the appropriate restrictive legend as required under the U.S. Securities Act.
ABOUT ORCHID VENTURES, INC. Orchid Ventures, Inc. is an Irvine, CA-based multi-state brand that launched in Oregon and California in August 2017 and has since developed a mass-market brand and loyal consumer following with its premium vape products. Orchid’s products lines are currently sold in 350+ dispensaries across California and Oregon and are handcrafted and designed for maximum flavor and overall enjoyment. The company’s proven processes and passion for what it does carry through into its products. The end result is an unparalleled experience for new and practiced cannabis users alike. Orchid plans to expand its brand into new national markets as well as global markets such as Latin America and Europe. With a continued focus on brand and intellectual property development, Orchid will execute strategic acquisitions to solidify an integrated cannabis manufacturing and distribution infrastructure with the goal of becoming a dominant premium cannabis brand in the United States. Orchid’s management brings significant branding, product development and distribution experience with a proven track record of scaling revenues, building value generating partnerships and creating enterprise value. Learn more at https://orchidessentials.com/
ON BEHALF OF THE BOARD OF DIRECTORS – ORCHID VENTURES, INC.
Corey Mangold CEO, Founder and Director
[email protected] 949-769-3859
THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE
Safe Harbor Statement Except for historical information contained herein, statements in this release may be forward-looking and made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Words such as “anticipate”, “believe”, “estimate”, “expect”, “intend” and similar expressions, as they relate to Orchid Ventures, Inc. and Orchid Essentials (collectively, the “Company”) or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the Company’s business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in the Company’s Canadian securities regulatory filings with sedar.com, Factors which could cause actual results to differ materially from these forward-looking statements include such factors as (i) the development and protection of our brands and other intellectual property, (ii) the need to raise capital to meet business requirements, (iii) significant fluctuations in marketing expenses, (iv) the ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of our products and services, (v) the Company’s ability to conduct the business if there are changes in laws, regulations, or government policies related to cannabis, (vi) management’s ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and (vii) other information that may be detailed from time to time in the Company’s Canadian securities regulatory filings with sedar.com. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
SOURCE: Orchid Essentials
View source version on accesswire.com: